Glaucoma Trial, Recruiting (NCT06808633)

Glaucoma Trial, Recruiting NCT06808633 Sponsor: Clínica Rementería Condition: Glaucoma

Printed from Voxsanity (voxsanity.com.au) — NCT06808633 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Glaucoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People who have been diagnosed with open-angle glaucoma (a type of glaucoma where the drainage angle of the eye remains open, but eye pressure is too high and there is damage to the optic nerve), where the treating doctor has recommended laser treatment for both eyes

Who may not be able to join:

People diagnosed with uveitic glaucoma (glaucoma linked to eye inflammation), angle-closure glaucoma (where the drainage angle of the eye is blocked), or glaucoma present from birth
People who have a condition called anterior peripheral synechiae, where parts of the iris (the coloured part of the eye) have become stuck to other eye structures (confirm with trial site)
People who are not able to attend follow-up appointments at three months, six months, and twelve months after treatment
People who have had surgery inside the eye, unless the only surgery was a straightforward cataract removal procedure that took place at least six months before joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +34913083838

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06808633

Sponsor: Clínica Rementería

Phase: Not Applicable

Status: Recruiting

Condition: Glaucoma

Trial contact: +34913083838

More information: https://clinicaltrials.gov/study/NCT06808633

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People who have been diagnosed with open-angle glaucoma (a type of glaucoma where the drainage angle of the eye remains open, but eye pressure is too high and there is damage to the optic nerve), where the treating doctor has recommended laser treatment for both eyes

Who may not be able to join:

People diagnosed with uveitic glaucoma (glaucoma linked to eye inflammation), angle-closure glaucoma (where the drainage angle of the eye is blocked), or glaucoma present from birth
People who have a condition called anterior peripheral synechiae, where parts of the iris (the coloured part of the eye) have become stuck to other eye structures (confirm with trial site)
People who are not able to attend follow-up appointments at three months, six months, and twelve months after treatment
People who have had surgery inside the eye, unless the only surgery was a straightforward cataract removal procedure that took place at least six months before joining the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Clínica Rementería

Registry

ClinicalTrials.gov

Start date

1 March 2025

Est. completion

20 September 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Percentage change in IOP six months after DSLT compared to baseline.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov